DuPont, US26614N2018

DuPont stock reports stronger Q2 earnings and 2026 guidance

Published on 10/03/2026 at 22:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Goldman Sachs cut its target to USD 153 on September 30, from USD 159. DuPont's full-year sales outlook stands at USD 7.16-7.19 billion after its Q2 beat.

Luftaufnahme einer modernen Spezialchemie-Produktionsanlage bei Sonnenuntergang
DuPont de Nemours Spezialchemie Anlage ISIN US26614N1028 bei Sonnenuntergang aus der Vogelperspektive fotografiert, Illustration mit AI erstellt.

DuPont stock (ISIN US26614N2018) was last at USD 129.98 on the NYSE on October 2, 2026, up 0.60 percent, with a market capitalization of USD 17.5 billion. The latest catalyst is a new sugar-separation tool, while the stronger investment case rests on DuPont's raised 2026 outlook.

Q2 earnings beat expectations

DuPont de Nemours delivered adjusted earnings per share of USD 1.88 in Q2 2026, exceeding the USD 1.76 consensus by USD 0.12, according to MarketBeat in its September 30, 2026 report. Revenue reached USD 1.82 billion in the quarter, 4 percent above the prior-year period.

The comparison matters because DuPont's adjusted EPS was USD 1.12 in the year-earlier quarter, putting the latest result USD 0.76 higher. The same report said third-quarter 2026 adjusted EPS guidance was USD 1.80-1.90.

Guidance sets the valuation debate

Zacks reported on October 2, 2026, that DuPont raised the midpoint of its full-year 2026 outlook after the Q2 performance. The company now expects net sales of USD 7.16 billion to USD 7.19 billion, operating EBITDA of USD 1.75 billion to USD 1.77 billion and adjusted EPS of USD 7.17 to USD 7.32.

That guidance gives investors a concrete yardstick for the next report: second-half sales are projected at USD 3.66 billion to USD 3.69 billion, while second-half operating EBITDA is expected at USD 890 million to USD 910 million. The ranges also show that execution in the water, healthcare and industrial markets remains central to the earnings profile.

Goldman Sachs lowers its target

MarketBeat reported that Goldman Sachs cut its DuPont price target from USD 159 to USD 153 on September 30, 2026, while keeping a neutral rating. The move contrasts with the earnings beat and puts greater weight on whether the raised outlook converts into cash generation.

The latest product launch adds an operating detail to that debate. DuPont's Sugar Separation Advisor helps producers evaluate chromatographic separation options and identify AmberLite resins for further testing, according to Zacks on October 2, 2026.

Stock remains below its yearly high

DuPont's USD 129.98 last price on the NYSE on October 2, 2026 compares with a 52-week range of USD 92.46 to USD 157.98. Trading volume was 644,991 shares, giving the market a clear reference point as investors weigh the guidance range against the lower Goldman Sachs target.

DuPont stock at a glance

  • Company: DuPont de Nemours, Inc.
  • ISIN: US26614N2018
  • Ticker: DD
  • Trading venue: NYSE
  • Price (as of October 2, 2026, 4:00 p.m. ET): USD 129.98
  • Market capitalization: USD 17.5 billion (as of October 2, 2026)
  • 52-week range: USD 92.46-157.98 (as of October 2, 2026)
  • Sector / Industry: Basic Materials / Chemicals

More news and analyses on DuPont stock

Disclaimer...

en | US26614N2018 | DUPONT | boerse | 70221722 | bgmi